Doctor Marin Vidak

Doctor Marin Vidak

University Hospital Dubrava, Zagreb (Croatia)

Member of:

Association for Acute CardioVascular Care

Cardiology resident and scientific associate with a PhD in translational research, combining clinical work with academic and scientific engagement. Particularly interested in intensive cardiology and heart failure, with a strong foundation in medical education and research integrity. Author of numerous peer-reviewed publications in heart failure, clinical trial methodology, and bioethics. Recognized with multiple international awards for scientific presentations and actively involved in collaborative cardiovascular research across European networks. Committed to advancing patient care through ethical, evidence-based medicine and academic excellence.

Presentations

Characteristics, adverse event reporting and completeness of intervention description in short-term mechanical circulatory support trials: an observational study

Event: ESC Acute CardioVascular Care 2026

Topic: Nonpharmacological Treatment

Session: Shocking hemodynamics and complications in myocarditis, pulmonary hypertension and mechanical circulatory support

Access

Glucagon-like peptide-1 receptor agonists and sodium glucose cotransporter-2 inhibitors combination therapy after acute myocardial infarction in patients with type 2 diabetes mellitus: a dynamic duo

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Pharmacotherapy in coronary artery disease (2)

Access

Prevalence, prognosis, and factors associated with heart failure with improved ejection fraction: single centre experience

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Trends and challenges in heart failure management

Access

The role of C-reactive protein-albumin and red blood cell distribution width to albumin level ratio change in patients with heart failure in the SGLT2 era

Event: ESC Congress 2025

Topic: Biomarkers

Session: Diagnosis and biomarkers of heart failure

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Marin Vidak

Biography

Contributor content

Characteristics, adverse event reporting and completeness of intervention description in short-term mechanical circulatory support trials: an observational study

Glucagon-like peptide-1 receptor agonists and sodium glucose cotransporter-2 inhibitors combination therapy after acute myocardial infarction in patients with type 2 diabetes mellitus: a dynamic duo

Prevalence, prognosis, and factors associated with heart failure with improved ejection fraction: single centre experience

The role of C-reactive protein-albumin and red blood cell distribution width to albumin level ratio change in patients with heart failure in the SGLT2 era

ESC 365 is supported by

Doctor Marin Vidak Follow

Biography

Contributor content

Characteristics, adverse event reporting and completeness of intervention description in short-term mechanical circulatory support trials: an observational study

Glucagon-like peptide-1 receptor agonists and sodium glucose cotransporter-2 inhibitors combination therapy after acute myocardial infarction in patients with type 2 diabetes mellitus: a dynamic duo

Prevalence, prognosis, and factors associated with heart failure with improved ejection fraction: single centre experience

The role of C-reactive protein-albumin and red blood cell distribution width to albumin level ratio change in patients with heart failure in the SGLT2 era

ESC 365 is supported by

Doctor Marin Vidak